Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

A Dilemma for Governments: How to Pay for Million-Dollar Therapies

The New York Times – Business:

A wave of transformative but hugely expensive treatments is challenging the budgets of health systems in wealthy nations. Now countries with far fewer resources are wrestling with how to cover the therapies.

Rebecca Robbins
Author: Rebecca Robbins

This post first appeared in The New York Times – Business. Read the original article.

Written by

Rebecca Robbins

in

Brazil, Children and Childhood, Disabilities, Drugs (Pharmaceuticals), Genetic Engineering, Genetics and Heredity, Medicine and Health, Novartis AG, Spinal Muscular Atrophy, Suits and Litigation (Civil)
←Long Covid Is Keeping Significant Numbers of People Out of Work, Study Finds
Judge To Hold Hearing Over Georgia Special Grand Jury Report→

More posts

  • Buyers Move For German Crime Drama ‘SOKO’ As ZDF Studios Brings Classic & YA Series To Cannes

  • ‘A Haunting’ Revived At Radial Entertainment With Jupiter Pictures Producing: “We Are Focused On Where The Audience Is”

  • New rule, no change – has cricket missed a trick again with bad light?

  • John Oliver Has A Message For His New Skydance Overlords

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube